Synagis 100 mg (Palivizumab SOLUTION) 100 MG

SYNAGIS 100 MG is a solution used for respiratory syncytial virus (RSV) prevention. This medication, containing palivizumab, is administered intramuscularly to reduce the risk of severe RSV infections in high-risk individuals.

Strength

100 MG

Pack Size

0.5ML/1ML

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SYNAGIS 100 MG is primarily used for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). It is often prescribed for individuals at high risk of severe RSV infections, such as premature infants or those with chronic lung disease. The medication works by neutralizing the RSV virus, helping to protect vulnerable patients during RSV season.

Side Effects

Common effects of SYNAGIS 100 MG may include mild redness, swelling, or pain at the injection site. Some individuals might experience fever, irritability, or mild gastrointestinal discomfort. These effects are generally temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare provider immediately.

Precautions & Warnings

SYNAGIS 100 MG should be handled with care and stored as directed to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before administration. The medication should be used under medical supervision, and any unusual symptoms should be reported promptly.

Avoid Interactions

SYNAGIS 100 MG may interact with other medications, particularly those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of the medication, so caution is recommended.

Frequently Asked Questions

SYNAGIS 100 MG is used to prevent serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk individuals.

SYNAGIS 100 MG is administered intramuscularly, typically by a healthcare professional.

Common side effects may include mild redness, swelling, or pain at the injection site, as well as fever or irritability.

Individuals with known allergies to palivizumab or any of the ingredients in SYNAGIS 100 MG should avoid using it. Always consult a healthcare provider for personalized advice.

SYNAGIS 100 MG may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.